Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Microbiol.

Sec. Microorganisms in Vertebrate Digestive Systems

Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1635962

This article is part of the Research TopicThe Role of Gut Microbes and Their Metabolites in Metabolic Diseases: Mechanisms and Therapeutic TargetsView all 9 articles

Identifying gut microbiota Faecalibacterium as a potential biomarker for distinguishing visceral or subcutaneous obese population Runing Title:Distinguishing visceral or subcutaneous obese population by Faecalibacterium

Provisionally accepted
Zhonghui  FengZhonghui Feng1*Yi  LiYi Li2Senlin  WangSenlin Wang1Song  ZhangSong Zhang3Ergan  LiErgan Li4Meifang  LiangMeifang Liang5Youqin  LiYouqin Li5Anke  LiuliAnke Liuli5Li  DengLi Deng5Liu  YanjunLiu Yanjun1Tongtong  ZhangTongtong Zhang1Xin  DiXin Di6Yongmei  LiYongmei Li2
  • 1Chengdu Third People's Hospital, Chengdu, China
  • 2The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
  • 3The Affiliated Hospital of Qingdao University, Qingdao, China
  • 4Southwest Minzu University, Chengdu, China
  • 5Southwest Jiaotong University, Chengdu, China
  • 6The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China

The final, formatted version of the article will be published soon.

Background Obesity is a global health issue, with sharply increasing rates due to excessive food intake and reduced physical activity, leading to an increased risk of various chronic diseases, such as type 2 diabetes and cardiovascular diseases. Fat distribution plays a significant role in health, with visceral fat being particularly associated with metabolic syndrome. Currently, computed tomography (CT) and magnetic resonance imaging (MRI) are the gold standards for measuring visceral fat, but they are costly and involve radiation risks.The gut microbiota is closely related to obesity, and dysbiosis may lead to obesity and metabolic disorders. Research on the relationship between visceral fat and the gut microbiota can aid in the development of new diagnostic and therapeutic approaches.We selected 31 participants with class II obesity(body mass index between 35 and 40) and divided those samples into two groups on the basis of their VSR(visceral-to-subcutaneous fat volume ratio) measured by CT,analyzed their fecal Microbiota through 16S rDNA sequencing.Results reveal significant differences in microbial composition between the visceral and subcutaneous obesity groups through 16S analysis of their fecal microbiota. The visceral obesity group presented a greater abundance of the Blautia genus, whereas the subcutaneous obesity group presented a greater abundance of the Faecalibacterium genus. Species difference analysis and clinical correlation analysis revealed that Blautia and Faecalibacterium were associated with visceral and subcutaneous obesity, respectively, and played opposite roles. Moreover, in our validation cohort (n=16), we also found that the subcutaneous obesity group had a greater abundance of the Faecalibacterium genus.This study measured visceral and subcutaneous fat volumes via CT and revealed that the composition of the gut microbiota is related to the type of obesity. In addition, we found that Blautia and Faecalibacterium were associated with visceral and subcutaneous obesity, which provides new insights for the diagnosis and treatment of obesity.

Keywords: Key word:Obesity, visceral fat, Subcutaneous Fat, Gut Microbiota, Faecalibacterium 1. Introduction

Received: 27 May 2025; Accepted: 13 Aug 2025.

Copyright: © 2025 Feng, Li, Wang, Zhang, Li, Liang, Li, Liuli, Deng, Yanjun, Zhang, Di and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Zhonghui Feng, Chengdu Third People's Hospital, Chengdu, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.